Issue 125 • December 2022Inside the European mass shift to data-driven health solutionsChronic drug shortages signal difficult outlook for cardiovascular care‘Twindemic’ risks warrant immediate steps in Europe and the USIn association withWhat Rishi Sunak can do for the UK pharma industryAmidst a swap in UK leadership, the pharmaceutical industry hopes Rishi Sunak will free up funding and boost the economy In association withIssue 125Brought to you by02/24/2024 03:51:49